Skip to main navigation Skip to search Skip to main content

NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody

  • Xiaoyong Guo
  • , Changjian Li
  • , Xiaohua Jia
  • , Yawei Qu
  • , Miaomiao Li
  • , Caiguang Cao
  • , Zeyu zhang
  • , Qiaojun Qu
  • , Shuangling Luo
  • , Jianqiang Tang*
  • , Haifeng Liu*
  • , Zhenhua Hu*
  • , Jie Tian*
  • *Corresponding author for this work
  • General Hospital of Chinese People's Armed Police Forces
  • CAS - Institute of Automation
  • Harbin Institute of Technology
  • Beijing Mentougou District Hospital
  • University of Chinese Academy of Sciences
  • Shanxi Medical University
  • Sixth Affiliated Hospital of Sun Yat-Sen University
  • Chinese Academy of Medical Sciences

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Surgery is the cornerstone of colorectal cancer (CRC) treatment, yet complete removal of the tumour remains a challenge. The second near-infrared window (NIR-II, 1000–1700 nm) fluorescent molecular imaging is a novel technique, which has broad application prospects in tumour surgical navigation. We aimed to evaluate the ability of CEACAM5-targeted probe for CRC recognition and the value of NIR-II imaging-guided CRC resection. Methods: We constructed the probe 2D5-IRDye800CW by conjugated anti-CEACAM5 nanobody (2D5) with near-infrared fluorescent dye IRDye800CW. The performance and benefits of 2D5-IRDye800CW at NIR-II were confirmed by imaging experiments in mouse vascular and capillary phantom. Then mouse colorectal cancer subcutaneous tumour model (n = 15), orthotopic model (n = 15), and peritoneal metastasis model (n = 10) were constructed to investigate biodistribution of probe and imaging differences between NIR-I and NIR-II in vivo, and then tumour resection was guided by NIR-II fluorescence. Fresh human colorectal cancer specimens were incubated with 2D5-IRDye800CW to verify its specific targeting ability. Findings: 2D5-IRDye800CW had an NIR-II fluorescence signal extending to 1600 nm and bound specifically to CEACAM5 with an affinity of 2.29 nM. In vivo imaging, 2D5-IRDye800CW accumulated rapidly in tumour (15 min) and could specifically identify orthotopic colorectal cancer and peritoneal metastases. All tumours were resected under NIR-II fluorescence guidance, even smaller than 2 mm tumours were detected, and NIR-II had a higher tumour-to-background ratio than NIR-I (2.55 ± 0.38, 1.94 ± 0.20, respectively). 2D5-IRDye800CW could precisely identify CEACAM5-positive human colorectal cancer tissue. Interpretation: 2D5-IRDye800CW combined with NIR-II fluorescence has translational potential as an aid to improve R0 surgery of colorectal cancer. Fundings: This study was supported by Beijing Natural Science Foundation (JQ19027), the National Key Research and Development Program of China ( 2017YFA0205200), National Natural Science Foundation of China ( NSFC) ( 61971442, 62027901, 81930053, 92059207, 81227901, 82102236), Beijing Natural Science Foundation ( L222054), CAS Youth Interdisciplinary Team ( JCTD-2021-08), the Strategic Priority Research Program of the Chinese Academy of Sciences ( XDA16021200), the Zhuhai High-level Health Personnel Team Project (Zhuhai HLHPTP201703), the Fundamental Research Funds for the Central Universities ( JKF-YG-22-B005) and Capital Clinical Characteristic Application Research ( Z181100001718178). The authors would like to acknowledge the instrumental and technical support of the multi-modal biomedical imaging experimental platform, Institute of Automation, Chinese Academy of Sciences.

Original languageEnglish
Article number104476
JournaleBioMedicine
Volume89
DOIs
StatePublished - Mar 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CEACAM5
  • Colorectal cancer
  • Molecular imaging
  • Nanobody
  • Second near-infrared window

Fingerprint

Dive into the research topics of 'NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody'. Together they form a unique fingerprint.

Cite this